Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

Clinical trial NCT01004432 · COMPLETED

Trial details

NCT number: NCT01004432
Sponsor: Janssen Biotech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis Arthritis, Rheumatoid Autoimmune Diseases

Start date: 2009-12-01
Primary completion: 2013-07-01
Enrollment: 433

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.